Stay updated on Darolutamide in Addition to ADT Clinical Trial
Sign up to get notified when there's something new on the Darolutamide in Addition to ADT Clinical Trial page.

Latest updates to the Darolutamide in Addition to ADT Clinical Trial page
- Check2 days agoChange DetectedRecruitment status updated to 'No longer looking for participants,' indicating enrollment has ended. The record also shows a new revision version, v3.6.0.SummaryDifference0.2%

- Check9 days agoChange DetectedThe latest revision in the record history is now v3.5.5, replacing v3.5.4, indicating a minor metadata update to the page.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedNew revision tag v3.5.4 was added and the previous v3.5.3 tag was removed in the record history. This reflects a minor backend update to the page without altering study data or content.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page’s displayed software/version revision label was updated from v3.5.0 to v3.5.3, reflecting a site release rather than any change to the underlying trial record.SummaryDifference0.0%

- Check90 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the page history.SummaryDifference0.0%

- Check98 days agoChange DetectedFooter revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Darolutamide in Addition to ADT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Darolutamide in Addition to ADT Clinical Trial page.